|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0010674,
umls-concept:C0011847,
umls-concept:C0015663,
umls-concept:C0020456,
umls-concept:C0021641,
umls-concept:C0087111,
umls-concept:C0205207,
umls-concept:C0332161,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C1274040,
umls-concept:C1305855,
umls-concept:C1552599,
umls-concept:C1704787
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-10-1
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Cystic fibrosis-related diabetes (CFRD) without fasting hyperglycemia (CFRD FH-) is not associated with microvascular or macrovascular complications, leading to controversy about the need for treatment. The Cystic Fibrosis Related Diabetes Therapy (CFRDT) Trial sought to determine whether diabetes therapy improves BMI in these patients.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1935-5548
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1783-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
|
|
pubmed:affiliation |
University of Minnesota, Minneapolis, Minnesota, USA. moran001@umn.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
